Mark L. Offerhaus
Corporate Officer/Principal at Eco Investment Partners BV
Mark L. Offerhaus active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Eco Investment Partners BV | Corporate Officer/Principal | 2004-12-31 | - |
Career history of Mark L. Offerhaus
Former positions of Mark L. Offerhaus
| Companies | Position | Start | End |
|---|---|---|---|
Micreos BV
 Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Chief Executive Officer | 2004-12-31 | 2023-05-31 |
| Founder | 2004-12-31 | 2023-05-31 | |
Micreos Human Health BV
 Micreos Human Health BV BiotechnologyHealth Technology Micreos Human Health BV operates as biotechnology company, which engages in the provision of anti-bacterial products. It develops Gladskin, a technology that targets the harmful Staphylococcus aureus-bacterium, and eaves the good bacteria - essential for a healthy skin. The company is headquartered in The Hague, the Netherlands. | Chief Executive Officer | 2004-12-31 | 2023-05-31 |
Exponential Biotherapies, Inc.
 Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Director/Board Member | 2003-12-31 | 2003-12-31 |
| ING GROEP N.V. | Corporate Officer/Principal | 1985-12-31 | - |
Enuenu Life Insurance Co., Ltd.
 Enuenu Life Insurance Co., Ltd. Life/Health InsuranceFinance Part of ING Groep NV, Enuenu Life Insurance Co., Ltd. is a company based in Tokyo, Japan. The CEO of the Japanese company is Frank Eijsink. | President | - | - |
Training of Mark L. Offerhaus
| University of Leiden | Graduate Degree |
Statistics
International
| Netherlands | 6 |
| United States | 2 |
| Japan | 2 |
Operational
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ING GROEP N.V. | Finance |
| Private companies | 5 |
|---|---|
Micreos BV
Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Health Technology |
| Eco Investment Partners BV | |
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Health Technology |
Enuenu Life Insurance Co., Ltd.
Enuenu Life Insurance Co., Ltd. Life/Health InsuranceFinance Part of ING Groep NV, Enuenu Life Insurance Co., Ltd. is a company based in Tokyo, Japan. The CEO of the Japanese company is Frank Eijsink. | Finance |
Micreos Human Health BV
Micreos Human Health BV BiotechnologyHealth Technology Micreos Human Health BV operates as biotechnology company, which engages in the provision of anti-bacterial products. It develops Gladskin, a technology that targets the harmful Staphylococcus aureus-bacterium, and eaves the good bacteria - essential for a healthy skin. The company is headquartered in The Hague, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Mark L. Offerhaus
- Experience
